Premium
Venture capital and growth-equity investor SAIF Partners as well as private equity firm ChrysCapital have sold stakes in an Indian pharmaceutical company, taking advantage of a rally over the past few months. SAIF Partners has fully exited Mumbai-based Ipca Laboratories Ltd while ChrysCapital has sold part of its stake, regulatory filings ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
